192 related articles for article (PubMed ID: 12269390)
1. Apoptosis induced by activation of peroxisome-proliferator activated receptor-gamma is associated with Bcl-2 and NF-kappaB in human colon cancer.
Chen GG; Lee JF; Wang SH; Chan UP; Ip PC; Lau WY
Life Sci; 2002 Apr; 70(22):2631-46. PubMed ID: 12269390
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells.
Shimada T; Kojima K; Yoshiura K; Hiraishi H; Terano A
Gut; 2002 May; 50(5):658-64. PubMed ID: 11950812
[TBL] [Abstract][Full Text] [Related]
3. 15-PGJ2, but not thiazolidinediones, inhibits cell growth, induces apoptosis, and causes downregulation of Stat3 in human oral SCCa cells.
Nikitakis NG; Siavash H; Hebert C; Reynolds MA; Hamburger AW; Sauk JJ
Br J Cancer; 2002 Dec; 87(12):1396-403. PubMed ID: 12454768
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator activator receptor-gamma ligands, 15-deoxy-Delta(12,14)-prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways.
Zingarelli B; Sheehan M; Hake PW; O'Connor M; Denenberg A; Cook JA
J Immunol; 2003 Dec; 171(12):6827-37. PubMed ID: 14662889
[TBL] [Abstract][Full Text] [Related]
5. Ligands of peroxisome proliferator-activated receptor-gamma induce apoptosis in AR42J cells.
Masamune A; Satoh K; Sakai Y; Yoshida M; Satoh A; Shimosegawa T
Pancreas; 2002 Mar; 24(2):130-8. PubMed ID: 11854617
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
Grau R; Iñiguez MA; Fresno M
Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
[TBL] [Abstract][Full Text] [Related]
7. Diverse cardioprotective signaling mechanisms of peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt.
Zingarelli B; Hake PW; Mangeshkar P; O'Connor M; Burroughs TJ; Piraino G; Denenberg A; Wong HR
Shock; 2007 Nov; 28(5):554-63. PubMed ID: 17589386
[TBL] [Abstract][Full Text] [Related]
8. DR1-like element in human topoisomerase IIalpha gene involved in enhancement of etoposide-induced apoptosis by PPARgamma ligand.
Kanbe E; Abe A; Towatari M; Kawabe T; Saito H; Emi N
Exp Hematol; 2003 Apr; 31(4):300-8. PubMed ID: 12691917
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor-gamma activator 15-deoxy-Delta12,14-prostaglandin J2 inhibits neuroblastoma cell growth through induction of apoptosis: association with extracellular signal-regulated kinase signal pathway.
Kim EJ; Park KS; Chung SY; Sheen YY; Moon DC; Song YS; Kim KS; Song S; Yun YP; Lee MK; Oh KW; Yoon DY; Hong JT
J Pharmacol Exp Ther; 2003 Nov; 307(2):505-17. PubMed ID: 12966153
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin D2 and its metabolites induce caspase-dependent granulocyte apoptosis that is mediated via inhibition of I kappa B alpha degradation using a peroxisome proliferator-activated receptor-gamma-independent mechanism.
Ward C; Dransfield I; Murray J; Farrow SN; Haslett C; Rossi AG
J Immunol; 2002 Jun; 168(12):6232-43. PubMed ID: 12055237
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor-gamma represses GLUT4 promoter activity in primary adipocytes, and rosiglitazone alleviates this effect.
Armoni M; Kritz N; Harel C; Bar-Yoseph F; Chen H; Quon MJ; Karnieli E
J Biol Chem; 2003 Aug; 278(33):30614-23. PubMed ID: 12777391
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2, and ciglitazone, induce growth inhibition and cell cycle arrest in hepatic oval cells.
Cheng J; Nakamura H; Imanishi H; Liu W; Morisaki T; Sugiyama T; Hada T
Biochem Biophys Res Commun; 2004 Sep; 322(2):458-64. PubMed ID: 15325252
[TBL] [Abstract][Full Text] [Related]
13. The antiproliferative effects of PPARgamma ligands in normal human mammary epithelial cells.
Yee LD; Guo Y; Bradbury J; Suster S; Clinton SK; Seewaldt VL
Breast Cancer Res Treat; 2003 Mar; 78(2):179-92. PubMed ID: 12725418
[TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPARgamma.
Zander T; Kraus JA; Grommes C; Schlegel U; Feinstein D; Klockgether T; Landreth G; Koenigsknecht J; Heneka MT
J Neurochem; 2002 Jun; 81(5):1052-60. PubMed ID: 12065618
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 expression by nonsteroidal anti-inflammatory drugs in human airway smooth muscle cells: role of peroxisome proliferator-activated receptors.
Pang L; Nie M; Corbett L; Knox AJ
J Immunol; 2003 Jan; 170(2):1043-51. PubMed ID: 12517972
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of p21 gene expression by peroxisome proliferator-activated receptor gamma in human lung carcinoma cells.
Han S; Sidell N; Fisher PB; Roman J
Clin Cancer Res; 2004 Mar; 10(6):1911-9. PubMed ID: 15041706
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor-gamma upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells.
Burgermeister E; Tencer L; Liscovitch M
Oncogene; 2003 Jun; 22(25):3888-900. PubMed ID: 12813462
[TBL] [Abstract][Full Text] [Related]
18. 15-Deoxy-delta12,14-PGJ2, but not troglitazone, modulates IL-1beta effects in human chondrocytes by inhibiting NF-kappaB and AP-1 activation pathways.
Boyault S; Simonin MA; Bianchi A; Compe E; Liagre B; Mainard D; Bécuwe P; Dauça M; Netter P; Terlain B; Bordji K
FEBS Lett; 2001 Jul; 501(1):24-30. PubMed ID: 11457450
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells.
Hashimoto K; Ethridge RT; Evers BM
Int J Gastrointest Cancer; 2002; 32(1):7-22. PubMed ID: 12630765
[TBL] [Abstract][Full Text] [Related]
20. Effect of PPARgamma ligands on the viability of gastric epithelial cells.
Kojima K; Shimada T; Mitobe Y; Yoshiura K; Hiraishi H; Terano A
Aliment Pharmacol Ther; 2002 Apr; 16 Suppl 2():67-73. PubMed ID: 11966526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]